Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2022 | SKYSCRAPER-07: A phase III, randomized, double-blind, placebo-controlled study of atezolizumab with or without tiragolumab in patients with unresectable ESCC who have not progressed following definitive concurrent chemoradiotherapy | JOURNAL OF CLINICAL ONCOLOGY |